Company Medical Oncology Research Srl with Fiscal Code 36326327
recorded a turnover of 2024 of
89.159,
with a net profit of
60.641
and having an average number of employees of
- .
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Medical Oncology Research Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
7.452
28.358
59.440
110.319
64.796
44.023
58.999
70.426
89.159
Total Income - EUR
-
7.452
28.358
59.440
110.319
64.934
44.280
61.180
70.476
90.180
Total Expenses - EUR
-
549
98
692
562
13.168
14.379
14.884
23.233
26.833
Gross Profit/Loss - EUR
-
6.904
28.260
58.747
109.757
51.766
29.901
46.297
47.243
63.347
Net Profit/Loss - EUR
-
6.680
27.409
56.964
106.448
49.932
28.580
44.992
46.538
60.641
Employees
-
0
0
0
0
0
0
0
1
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 27.3%, from 70.426 euro in the year 2023, to 89.159 euro in 2024.
The Net Profit increased by 14.363 euro, from 46.538 euro in 2023, to 60.641 in the last year.
Check the financial reports for the company - Medical Oncology Research Srl
Financial Rating - MEDICAL ONCOLOGY RESEARCH SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Medical Oncology Research Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Medical Oncology Research Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Medical Oncology Research Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Medical Oncology Research Srl - CUI 36326327
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
0
0
0
585
34.123
25.892
20.579
12.466
5.945
Current Assets
-
6.915
27.840
57.074
112.120
47.684
38.806
85.718
85.752
131.160
Inventories
-
0
0
0
704
0
0
0
0
0
Receivables
-
0
1.538
37
76.222
13.864
7.353
35.631
4.369
17.021
Cash
-
6.915
26.302
57.037
35.193
33.821
31.453
50.086
81.383
114.140
Shareholders Funds
-
6.725
27.453
57.007
106.490
51.035
38.053
45.041
56.469
96.691
Social Capital
-
45
44
43
42
41
40
41
40
40
Debts
-
190
387
67
6.214
30.773
26.645
61.256
42.313
41.090
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
131.160 euro in 2024 which includes Inventories of
0 euro, Receivables of
17.021 euro and cash availability of
114.140 euro.
The company's Equity was valued at
96.691 euro, while total Liabilities amounted to
41.090 euro.
Equity increased by 40.538 euro, from 56.469 euro in 2023, to 96.691 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Medical Oncology Research Srl